These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Possible use of immunofluorescence in chronic agressive hepatitis]. Storch W; Emmrich R Dtsch Z Verdau Stoffwechselkr; 1973; 33(3):119-23. PubMed ID: 4599279 [No Abstract] [Full Text] [Related]
5. [Immunopathogenesis of chronic inflammatory liver diseases]. Meyer zum Büschenfelde Ergeb Inn Med Kinderheilkd; 1972; 32():31-81. PubMed ID: 4556562 [No Abstract] [Full Text] [Related]
6. Immunological factors in the evolution of active chronic hepatitis and other autoimmune liver diseases. Smith MG; Eddleston AL; Williams R Clin Gastroenterol; 1975 May; 4(2):297-313. PubMed ID: 1092487 [No Abstract] [Full Text] [Related]
7. Viral hepatitis related antigens in 'autoimmune' hepatic disorders. Doniach D; Del Prete S; Dane DS; Walsh JH Can Med Assoc J; 1972 Feb; 106(Spec Issue):Suppl:513-8. PubMed ID: 4111527 [No Abstract] [Full Text] [Related]
8. [Australia antigen in chronic aggressive hepatitis and liver cirrhosis. Its significance for the etiology and pathogenesis of chronic inflammatory liver diseases]. Müller R; Kalden JR; Baruth B; Deicher H Dtsch Med Wochenschr; 1972 Mar; 97(10):369-75. PubMed ID: 4622158 [No Abstract] [Full Text] [Related]
9. Antinuclear antibody (ANA) patterns in hepatic and extrahepatic autoimmune disease. Strassburg CP; Manns MP J Hepatol; 1999 Oct; 31(4):751. PubMed ID: 10551402 [No Abstract] [Full Text] [Related]
12. Features of autoimmunity in cryptogenic chronic hepatitis. Provenzano G; Marino L; Craxì A Allergol Immunopathol (Madr); 1991; 19(3):119-22. PubMed ID: 1799170 [TBL] [Abstract][Full Text] [Related]
13. Bile canalicular antibody in primary biliary cirrhosis and in other liver diseases. MacSween RN; Armstrong EM; Gray KG; Mason M Lancet; 1973 Jun; 1(7817):1419-21. PubMed ID: 4122987 [No Abstract] [Full Text] [Related]
14. [Significance of immune histological findings for indication of immunosuppressive therapy in chronic aggressive hepatitis]. Storch W; Emmrich R; Petzold H Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:174-6. PubMed ID: 4580507 [No Abstract] [Full Text] [Related]
15. The immunology of liver disorders. Walker G Proc R Soc Med; 1974 Jun; 67(6 Pt 2):566-73. PubMed ID: 4605272 [No Abstract] [Full Text] [Related]
16. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101 [TBL] [Abstract][Full Text] [Related]
17. [Antibodies against mitochondria, smooth muscle and nuclei in chronic liver diseases]. Hauftová D; Macák J Vnitr Lek; 1976 Dec; 22(12):1185-91. PubMed ID: 1087498 [No Abstract] [Full Text] [Related]
18. Autoimmunity in hepatitis. Plotz PH Med Clin North Am; 1975 Jul; 59(4):869-76. PubMed ID: 49466 [No Abstract] [Full Text] [Related]
19. Autoimmune aspects of liver disease. Doniach D Br Med Bull; 1972 May; 28(2):145-8. PubMed ID: 4562014 [No Abstract] [Full Text] [Related]
20. [Immune processes implicated or associated in evolution of chronic hepatitis and liver cirrhosis]. Runcan V; Micu D; Stoica G; State IN; Hoancă O Med Interna (Bucur); 1972 Jun; 24(6):669-76. PubMed ID: 4560768 [No Abstract] [Full Text] [Related] [Next] [New Search]